Streetbeat News

Revenues

CNBS

CRLBF

JUSHF

TCNNF

Tim Seymour, portfolio manager of the Amplify Seymour Cannabis ETF (NYSE: CNBS), emphasizes the importance of state-level legalization over federal rescheduling for cannabis industry growth. He highlights the potential in states like Ohio, Florida, and Pennsylvania, and mentions companies like Cresco Labs, Trulieve, and Jushi Holdings as well-positioned to benefit from these changes.

Portfolio Pulse from Nicolás Jose Rodriguez

June 18, 2024 | 3:20 pm

PSX

Phillips 66 CEO stated at the JP Morgan Conference that the company continues to export Canadian crude despite the startup of the Trans Mountain Expansion (TMX) pipeline, which has tightened margins.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 3:12 pm

RELI

Reliance Global Group, Inc. (NASDAQ:RELI) shares surged 245% after the company updated on its pending acquisition of Spetner Associates, projecting to double annual revenues to $28 million. The acquisition's impact is surpassing expectations, with Spetner’s BenManage segment now covering 85,000 employees. Heavy trading volume was noted with over 46 million shares traded.

Portfolio Pulse from Erica Kollmann

June 18, 2024 | 3:11 pm

AAPL

AMZN

GLD

GOOG

META

MSFT

NVDA

QQQ

SLV

SPY

TSLA

USO

The article discusses the current state of the stock market, highlighting the momentum-driven rally in AI stocks and the potential risks associated with it. It mentions the SPDR S&P 500 ETF Trust (SPY) as a key indicator, noting its overbought status and low trading volume. The article also covers the recent retail sales data, which came in below expectations, and the bankruptcy filing of Fisker Inc. Additionally, it provides insights into early trade money flows for major tech stocks and ETFs, as well as the behavior of the 'momo crowd' and 'smart money' in various asset classes.

Portfolio Pulse from The Arora Report

June 18, 2024 | 3:06 pm

BTCUSD

DOGEUSD

PYPL

Elon Musk plans to integrate a payments network into X, aiming to transform it into an 'everything app.' The new features will resemble Venmo, allowing users to store money, make payments, and purchase goods. Despite a 40% revenue decline in the first half of 2023, X is pushing forward with securing money transmitter licenses in the U.S. and plans to launch payment services later this year.

Portfolio Pulse from Murtuza Merchant

June 18, 2024 | 3:05 pm

UNIUSD

Uniswap (UNI) has experienced a significant price drop of 13.33% within the last 24 hours, falling to $9.52. This contrasts with its positive trend over the past week, where it gained 4.0%. Trading volume has decreased by 14.0%, while circulating supply increased by 0.8%.

Portfolio Pulse from Benzinga Insights

June 18, 2024 | 3:03 pm

ADBE

CRM

INTU

SAP

WDAY

The article provides a comprehensive analysis of Workday (NASDAQ:WDAY) compared to its major competitors in the software industry. It highlights Workday's financial metrics, market position, and growth potential, indicating that the company is undervalued based on PE, PB, and PS ratios but faces operational inefficiencies with low ROE, EBITDA, and gross profit. However, Workday's high revenue growth and favorable debt-to-equity ratio suggest strong top-line performance and financial health.

Portfolio Pulse from Benzinga Insights

June 18, 2024 | 3:00 pm

MLSS

Milestone Scientific has received ANVISA approval to market its CompuFlo Epidural System in Brazil. The company aims to expand its addressable market by leveraging the technological advantages of its system. Brazil conducts 4-5 million epidural procedures annually.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 3:00 pm

MRK

The article provides a detailed competitor analysis of Merck & Co (NYSE:MRK) within the Pharmaceuticals industry, comparing key financial metrics, market positioning, and growth prospects against its primary competitors. Merck & Co shows a high PE ratio, indicating potential overvaluation, but has a low PB and PS ratio, suggesting undervaluation. The company has a high ROE but lower EBITDA, gross profit, and revenue growth compared to industry averages.

Portfolio Pulse from Benzinga Insights

June 18, 2024 | 3:00 pm

NKE

Nike (NYSE:NKE) has significantly outperformed the market over the past 20 years, delivering an average annual return of 12.22%. A $1000 investment in NKE 20 years ago would be worth $10,440.88 today. This highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

June 18, 2024 | 3:00 pm